Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies

Anaïs Lozach

 
 
share with twitter share with LinkedIn share with facebook
share via e-mail

There is still some upside potential

Strategy published on 10/06/2017 | 14:09
long trade
Live
Entry price : 205.97$ | Target : 230$ | Stop-loss : 193.7$ | Potential : 11.67%
The timing appears opportune to go long in shares of Illumina as we anticipate another pick-up in the underlying trend.
Investors have an opportunity to buy the stock and target the $ 230.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The tendency within the weekly time frame is positive above the technical support level at 160.42 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 210.72.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 38.97 and 51.41 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
ILLUMINA63.92%30 705
THERMO FISHER SCIENTIFIC IN..37.39%77 329
DANAHER16.64%63 154
INTUITIVE SURGICAL74.83%41 191
BOSTON SCIENTIFIC CORPORATI..37.26%40 738
ROYAL PHILIPS22.09%39 253
CERNER54.13%24 209
EDWARDS LIFESCIENCES CORP20.68%23 878
AGILENT TECHNOLOGIES INC47.61%21 643
WATERS CORPORATION40.00%15 018
OLYMPUS CORP-0.74%12 103
RESMED INC.27.32%11 242
RESMED INC. (CHESS)16.43%11 155
HOLOGIC-7.75%10 380
VARIAN MEDICAL SYSTEMS, INC..35.52%9 794
PERKINELMER, INC.37.55%7 906
More Results
Financials ($)
Sales 2017 2 684 M
EBIT 2017 645 M
Net income 2017 792 M
Finance 2017 821 M
Yield 2017 -
P/E ratio 2017 38,97
P/E ratio 2018 51,41
EV / Sales 2017 11,1x
EV / Sales 2018 9,67x
Capitalization 30 705 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ILLUMINA
Duration : Period : Day
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Duration : Period : Week
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders